KYMR · Kymera Therapeutics, Inc.
$117.39
+2.97 (+2.60%)
At close · Aug 14
Market Cap
$9.76B
Shares
83.15M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding KYMR
348 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Growth Company Fund | — | 2,185,407 | $177,935,838 | 0.18% | Long | 2026-05-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 2,082,159 | $173,423,023 | 0.01% | Long | 2026-03-31 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 1,946,980 | $162,163,964 | 1.27% | Long | 2026-03-31 | |
| VANGUARD HEALTH CARE FUND | — | 1,796,469 | $145,639,742 | 0.40% | Long | 2026-04-30 | |
| VANGUARD SMALL-CAP INDEX FUND | — | 1,505,906 | $125,426,911 | 0.08% | Long | 2026-03-31 | |
| SMALLCAP World Fund Inc | — | 1,486,128 | $123,779,601 | 0.15% | Long | 2026-03-31 | |
| iShares Russell 2000 ETF | — | 1,400,582 | $116,654,475 | 0.16% | Long | 2026-03-31 | |
| T. Rowe Price Capital Appreciation Fund | — | 1,389,400 | $115,723,126 | 0.17% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | — | 1,039,280 | $86,561,631 | 1.16% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 1,002,367 | $83,487,147 | 0.77% | Long | 2026-03-31 | |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | — | 841,854 | $70,118,020 | 0.18% | Long | 2026-03-31 | |
| T. Rowe Price Small-Cap Stock Fund, Inc. | — | 790,951 | $65,878,309 | 0.82% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 686,061 | $57,142,021 | 0.07% | Long | 2026-03-31 | |
| Eventide Healthcare & Life Sciences Fund | — | 626,000 | $52,139,540 | 3.28% | Long | 2026-03-31 | |
| VANGUARD EXPLORER FUND | — | 635,592 | $51,527,443 | 0.24% | Long | 2026-04-30 | |
| Fidelity Growth Company K6 Fund | — | 606,740 | $49,400,771 | 0.18% | Long | 2026-05-31 | |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund | — | 567,076 | $47,231,760 | 0.57% | Long | 2026-03-31 | |
| Fidelity Small Cap Index Fund | — | 567,116 | $45,976,094 | 0.14% | Long | 2026-04-30 | |
| Select Biotechnology Portfolio | — | 556,441 | $45,305,426 | 0.86% | Long | 2026-05-31 | |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | — | 525,000 | $43,727,250 | 0.19% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | — | 521,385 | $43,426,157 | 0.53% | Long | 2026-03-31 | |
| Fidelity Series Growth Company Fund | — | 531,529 | $43,277,091 | 0.18% | Long | 2026-05-31 | |
| Fidelity Contrafund | — | 506,025 | $42,146,822 | 0.03% | Long | 2026-03-31 | |
| iShares Russell 2000 Growth ETF | — | 468,547 | $39,025,280 | 0.32% | Long | 2026-03-31 | |
| Select Health Care Portfolio | — | 450,000 | $36,639,000 | 0.63% | Long | 2026-05-31 | |
| T. Rowe Price Institutional Small-Cap Stock Fund | — | 427,717 | $35,624,549 | 0.82% | Long | 2026-03-31 | |
| T. Rowe Price All-Cap Opportunities Fund | — | 388,442 | $32,353,334 | 0.23% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 317,300 | $25,834,566 | 0.06% | Long | 2026-05-31 | |
| Fidelity Small Cap Growth Fund | — | 316,053 | $25,622,417 | 0.30% | Long | 2026-04-30 | |
| Fidelity Stock Selector Small Cap Fund | — | 314,000 | $25,455,980 | 0.37% | Long | 2026-04-30 | |
| Fidelity Advisor New Insights Fund | — | 300,600 | $25,036,974 | 0.11% | Long | 2026-03-31 | |
| JNL/T. Rowe Price Capital Appreciation Fund | — | 292,300 | $24,345,667 | 0.18% | Long | 2026-03-31 | |
| Schwab U.S. Small-Cap ETF | — | 294,706 | $23,994,963 | 0.11% | Long | 2026-05-31 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 294,549 | $23,982,180 | 0.14% | Long | 2026-05-31 | |
| VIP Contrafund Portfolio | — | 287,200 | $23,920,888 | 0.09% | Long | 2026-03-31 | |
| Federated Hermes Kaufmann Fund | — | 294,095 | $23,842,282 | 0.51% | Long | 2026-04-30 | |
| Strategic Advisers Fidelity U.S. Total Stock Fund | — | 255,700 | $20,819,094 | 0.01% | Long | 2026-05-31 | |
| Federated Hermes Kaufmann Small Cap Fund | — | 236,238 | $19,151,815 | 0.67% | Long | 2026-04-30 | |
| Fidelity Advisor Biotechnology Fund | — | 231,700 | $18,783,919 | 0.99% | Long | 2026-04-30 | |
| AB Small Cap Growth Portfolio | — | 226,939 | $18,397,945 | 0.63% | Long | 2026-04-30 | |
| Fidelity Advisor Health Care Fund | — | 225,000 | $18,240,750 | 0.63% | Long | 2026-04-30 | |
| Putnam Small Cap Growth Fund | — | 216,994 | $18,073,430 | 0.67% | Long | 2026-03-31 | |
| Fidelity Series Small Cap Opportunities Fund | — | 221,000 | $17,916,470 | 0.36% | Long | 2026-04-30 | |
| PGIM Jennison Health Sciences Fund | — | 215,651 | $17,558,304 | 1.26% | Long | 2026-05-29 | |
| Global Small Capitalization Fund | — | 187,147 | $15,587,474 | 0.55% | Long | 2026-03-31 | |
| AB DISCOVERY GROWTH FUND, INC. | — | 186,016 | $15,080,317 | 0.56% | Long | 2026-04-30 | |
| Fidelity Series Opportunistic Insights Fund | — | 165,700 | $13,801,153 | 0.10% | Long | 2026-03-31 | |
| Driehaus Small Cap Growth Fund | — | 156,940 | $13,071,533 | 1.14% | Long | 2026-03-31 | |
| Fidelity SAI Small-Mid Cap Momentum Index Fund | — | 161,103 | $13,060,620 | 0.31% | Long | 2026-04-30 | |
| Fidelity Small Cap Growth K6 Fund | — | 157,460 | $12,765,282 | 0.30% | Long | 2026-04-30 |
Showing 1–50 of 348 positions
Key facts
CIK
1815442
CUSIP
501575104
13F (30d)
272 filings
270 filers
Visit website
Investor relations